Treating CLL patients with Richter transformation

A retrospective study of outcomes with ven-based treatment in cBTKi-treated, chemotherapy-naïve CLLПодробнее

Designing Research Trials for Richter’s Transformation - Dr. Adam KittaiПодробнее

Role of Stem Cell Transplants in Richter's Transformation - Dr. Adam KittaiПодробнее

A study investigating the efficacy of CAR-T therapy in Richter's transformationПодробнее

Triple Combination Therapy for Richter’s Transformation - Dr. Tamar Tadmor ASH 2023Подробнее

Chronic Lymphocytic Leukaemia (CLL) - New Study ResultsПодробнее

Dr. Kittai Discusses Richter Transformation in CLL: Unmet Needs, Novel TherapiesПодробнее

The mutational profile in patients with CLL treated with acalabrutinib or ibrutinibПодробнее

What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MDПодробнее

Epcoritamab Gives Deep Response in Richter’s TransformationПодробнее

Updates in CLL from EHA 2024: combinations of BTK and BCL2 inhibitors, BTK degraders, and moreПодробнее

MAIC of zanubrutinib and venetoclax + ibrutinib in treatment-naïve CLLПодробнее

Evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in Richter's transformationПодробнее

Incidence of Richter’s Transformation in the Targeted Therapy Era - Dr. Paul Hampel ASH 2023Подробнее

Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024Подробнее

CHRONIC LYMPHOCYTIC LEUKEMIA Pathogenesis CLL Criteria Diagnosis TreatmentПодробнее

Dr Winter on Unmet Needs in Richter Transformation for Patients With CLLПодробнее

A Phase II trial of pembrolizumab for Richter's transformation of CLLПодробнее

CAR T-Cell Therapy for Richter’s TransformationПодробнее

Advice for community physicians managing Richter's transformation of CLLПодробнее